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A wide variety of cytokines and chemokines are important modulators of immune response pathways (1) (2) (3) (4) (5) (6) (7) . These proteins are critical regulators of normal immune responses, inflammatory reactions and cell proliferation, and play key roles in chronic conditions such as heart disease, diabetes, and cancer, as well as acute conditions, such as infections (8) (9) (10) (11) (12) (13) (14) .
These immunologic mediators have traditionally been measured using enzyme-linked immunosorbent assay (ELISA) methods. However, these methods are costly, time consuming, requiring a relatively large sample size, and can only measure one analyte per assay kit. The Luminex multiplex immunoassay platform system is a highly efficient fluorescent (or magnetic) bead-based capture/detection sandwich immunoassay that allows for the efficient measurements of multiple analytes simultaneously in a single reaction vessel with small sample volumes (14) (15) (16) (17) (18) (19) .
In the field of immunoassay diagnostics there are gaps in knowledge that are barriers to full implementation of novel multiplex bead-based assay formats. What is the effect of anticoagulants on the precision and the concentrations of the analytes measured? Does age or sex affect the baseline levels of immune modulators in healthy subjects? The fundamental premise of biomarker identification is based on how discriminatory a specific analyte is for a specific disease or condition compared to a control group: ideally defined as a group of healthy subjects. In addition, the precision of these measurements is critical. Analytical variables, such as sample matrix effects, condition of storage (short or long term), type of specimen (plasma or serum) as well as choice of anticoagulants have been evaluated in the literature (9, 10, 15, (20) (21) (22) . This includes a recent study by Biancotto et al. (20) which analyzed 72 analytes in serum and plasma from 11 healthy donors as a function of anticoagulants, sodium heparin, acid citrate dextrose and EDTA.
In this study, we evaluated the precision and variation due to sample conditions of 23 serological markers. These include pro-inflammatory and anti-inflammatory cytokines, several receptors, chemokines, growth, and angiogenic factors. We measured the levels of these analytes in 107 healthy volunteers across a broad age range. The larger number of healthy subjects and well-defined subgroups in this study compared to earlier studies and a multivariate analysis approach add value to understanding the effect of analytical variables.
We show significant anticoagulant and age dependent differences in analytes concentrations, but the relative concentrations of the various analytes remain similar for a given anticoagulant. Ranges did not significantly differ between men and women, yet significant differences were noted due to age. These results should inform future studies using multiplex-bead technology to measure levels of these analytes as potential biomarkers for health, and disease states.
MATERIALS AND METHODS Study Design
Two independent studies were designed: to determine (a) precision of the measured analytes ( Fig. 1) and (b) variation in the measured analytes as a function of anticoagulants, sex, and age (Fig. 2) . Study subjects were healthy volunteer blood donors, ages of 18 to 85, recruited from Delta Blood Bank (Stockton, CA). The study was IRB approved and all subjects gave signed, informed consent. Twenty milliliters of peripheral venous blood was drawn into vacutainer tubes containing three different anticoagulants (citrate, EDTA, or Heparin) and without anticoagulant (serum) from the tubing used for blood donation. Samples were drawn, centrifuged immediately after blood draw, and plasma/serum was aliquotted and stored at 280 C. For the precision study ( Fig. 1 ), three samples from each age group (randomly selected two males and one female) were assayed three times in each plate and repeated three times (PL1, PL2, and PL3). This procedure was conducted for each of the samples collected in three anticoagulants and sera, leading to a total of 27 measurements per sample condition.
FIG. 1.
Study design for the precision of multiplex microbead assay. Data from three healthy subjects from each of the four age groups are repeated in three independent plates, three times each, leading to 27 replicates for each sample and a total of 108 samples per anticoagulants. Age groups I, II, III, and IV are defined to be 18 to 30, 31 to 50, 51 to 64, and 65 to 85 years old, respectively.
To determine the effect of age, sex and sample collection conditions, 107 individuals were used per preanalytical sample collection (Fig. 2) . Four age groups were defined as Group I (age range 18-30, with 20 females and 10 males), Group II (age range 31-50, 18 females and 13 males), Group III (age range 51-64, 15 females and males each), and Group IV (age range 65-85, 8 females and males each). All samples (precision and normal study) were assorted on the same plates sharing the wells to minimize laboratory batch effects.
Experimental Measurements
We measured a total of 23 cytokines, chemokines and growth factors using the Luminex multiplex bead-based technology; (IL-1b, IL-1ra, IL-2, IL-6, IL-7, IL-8, IL-12 p70, IL-17, IFN-g, IP-10, MCP-1, PDGF-BB, RANTES, TNF-a, IL1a, IL-16, HGF, MIG, TNF-b) (Bio-Rad, Hercules, CA) and PDGF-ABBB, EGF, Flt-3 Ligand, VEGF (Millipore, Billerica, MA). The assays were performed in accordance with manufacturers' protocols and methods which have been reported previously (23) . One plasma sample spiked with the analytes was measured in triplicate and used to determine the instrument coefficient of variation (CV). One sample was also spiked with the standards provided by the assay manufacturer and measured in triplicate at the same conditions and spike recovery was not evaluated.
Concentrations (pg/ml) of different analytes in the samples were determined by generating standard curves with the multiplex assay system. MasterPlex QT software for quantitation was used for five point curves fitting to generate standard curves and analyze data according to the manufacturer's instructions (MiraiBio, Alameda, CA). The analyte concentrations were transformed to log2 scale for further analysis to accommodate the dynamic range in the concentration values.
Statistical Methods
A linear model fit was determined for each analyte using the LIMMA package using R, and lists of analytes with the most evidence of differential levels between the groups (men vs. women; age group, sample collection type) were obtained. Significant analytes were selected by a two-step process. First, the initial data set consisted of measurement of all the analytes for which a signal was detected for at least one feature (e.g., age group) for one subject. Second, the data from all the subjects were combined into a single data set. The resulting combined data set consisted of analytes that exhibited modulation for at least one subject for at least one of the features tested. Differential measurements in patient samples across the age groups points (group I vs. groups II, III, and IV) were detected by an F test. Pvalues for different analytes were transformed to compensate for multiple comparisons using the False Discovery Rate (FDR) adjustment for multiple comparisons using the Benjamini-Hochberg procedure (24, 25) . Fold changes were derived from multivariate statistical analysis. This analysis allowed a comparison of more than one statistical variable in an age group and therefore increases the statistical dimensionality of the data to get a meaningful value for fold change and adjusted p-values for multiple comparisons.
Hierarchical cluster analysis was performed using a Euclidean distance metric without standardization to identify natural grouping of analyte profiles among the samples. To adjust for the large dynamic range between different microbead sets, the data were further scaled between the different analytes to give a relative intensity scale ranging from 22 to 2 and the clustered results were presented as dendograms and heat maps. All the analyses were performed with the Bioconductor and R software package (26) .
RESULTS

Coefficient of Variation of the Analytes
The first objective of this study was to determine the coefficient of variation (CV) of the analytes. Table 1 lists the measured CVs of all the analytes in the multiplex assay along with that for the spiked sample. The CVs of 17 of the 23 analytes was measureable in the assay, with the exception of IL-8, IL-17, TNF-b, EGF, and VEGF for all the sample collection types ( Table 1) . CVs of IL-1b, IL-1ra, IFG-g, IP-10, MCP-1, PDGF-BB, IL-16, HGF, MIG, and PDGF-ABBB were measurable in all the sample conditions. Citrate sample showed CVs ranging from 4.6% (MCP1) -25.1% (RANTES); EDTA samples showed CVs ranging from 4.7% (PDGF-ABBB)-21.2% (IL-6); heparin had a range of 6.5% (MIG)-26.7% (IL-1a) and serum samples had a range of 6.1% (MCP-1)-56.2% (IL-1ra). Samples collected in heparin showed generally higher CVs than the other sample types. The CV values of the raw MFI data (before conversion to concentration via standard curves) are in the same range as that calculated based on concentrations. The spiked sample had a range FIG. 2. Study design to determine the effect of anticoagulants and the variation related to age and sex in the multiplex microbead assay. Each age group is represented by approximately 30 samples (except for age group IV) and divided into subgroups according to sex, leading to a total of 107 samples per anticoagulant. Age groups I, II, III, and IV are defined to be 18 to 30, 31 to 50, 51 to 64, and 65 to 85 years old, respectively. of 1.7% to 6.6% for the 22 analytes, except for RANTES with a CV of 24%.
Analyte Concentrations
Twenty-two of the 23 analytes were detected across all the samples and in all age groups (Table 2) . IFN-g was the lowest detected (in average of 30% samples across all age groups) and therefore was not used in further analysis. IL-12p70, MCP-1, TNF-a, HGF, MIG, TNF-b, PDGF-ABBB, and VEGF were measured 100% of the time, and except for IL-1b (68% average), the remainder of the analytes were detected in >75% of all subjects. The concentrations varied considerably among the analytes (Fig. 1 , Table 2 ) and this observation is consistent with the ranges measured in other studies (20) . With reference to the mean value of a particular analyte across the different sample conditions, (age group differences vide supra), IL-2, EGF, and IL-6 showed the lowest difference (within the CV) across all the sample collection conditions, whereas PDGF-BB, RANTES, and PDGF-ABBB showed the largest differences. For these three analytes, samples collected in heparin showed the lowest average concentration, whereas the serum had the highest and this trend was observed for other analytes as well (Table 1) . For the analytes in the mid-range of concentrations, MIG and IP-10 showed the largest variations, with MIG having average high concentration in both samples collected in heparin and in sera, with much lower values for samples collected in citrate and EDTA.
Age Dependent Modulation of Analytes
Multivariate statistics were used to identify the analytes that showed significant changes in their levels across the age groups. The fold changes were calculated with reference to age group I so as to determine whether a particular analyte changed (either positively or negatively) with respect to the lowest age group. Table 3 lists the analytes that showed significant changes when compared, and Figure 3 highlights the results for IL-1b, IL-7, and TNF-a. Analytes were selected such that the fold changes with respect to group I is 1.5 times greater and a P value <0.05, in at least one of the comparisons (age groups I vs. II or III or IV) in all the sample conditions. The overall trend of the age dependent variations of the cytokines was similar in all sample conditions. IL-1b, IL-7, IL-12p70, and MIG were significantly higher with increase in age, while Flt-3 Ligand was lower. Variations with age were more prominent in the serum samples in comparison with others (Fig. 3, Table 3 ). It is important to note that none of the analytes showed significant differences between men and women in each age group and in all the sample conditions.
Interaction Between Age of the Subject and Anticoagulant
To determine the overall age dependent variation of all the analytes and the respective trends in the preexperimental sample conditions, a hierarchical cluster analysis was performed (Fig. 4) . The clustering analysis, using all the analytes (except IFN-g) clearly classified the sample conditions (horizontal dendograms , Fig. 4) ; heparin and serum samples profiles were different from each other while the profiles in citrate and EDTA were similar. In addition, the analytes group into three major clusters (vertical dendograms, Fig. 4) , represented by A, B and C. Analytes in group A (IL-1a, IL-16, MIG, MCP-1, and TNF-b) were elevated in samples collected in heparin, whereas lowered in both citrate and EDTA collected samples. In contrast, the analytes in group B (RANTES, IP-10, HGF, IL-8, IL-17, and PDGF-BB) were higher in the sera, but relatively low in all the other three conditions. The third larger group of analytes designated as C, showed low levels in the heparin but higher levels in citrate, EDTA, and serum. The effect of age on the individual analytes was also sequentially related within the group (in the order I, II, III, and IV for heparin and serum). It is interesting to note that Flt-3 Ligand, which showed an increase in the levels upon aging, did not cluster with any one of the groups. I, II, III, IV represent age groups 18 to 30, 31 to 50, 51 to 64, and 65 to 85 years old, respectively; SD: standard deviation; %: percentage of samples that have measureable concentrations above the limit of detection. 
DISCUSSION
Variation effects on the quantitative determination of the concentration of 23 different peripheral blood analytes of healthy subjects collected in three different anticoagulants and sera were measured. Because the group of individuals was large (n 5 107), we were able to address additional issues, related to the possible effect that age and sex of the subjects might have on the biomarker analyte levels.
There are complex changes in the immune system associated with age. These changes include reduction in response and modulation in regulatory and immune effector cells leading to changes in expression of various chemokines and cytokines (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) . Shurin et al. (37) investigated the effect of age on 30 different serum biomarkers involved in pro-and anti-inflammatory responses. These measurements were performed in healthy subjects between 40 and 80 years old. The overall trends in our measurements for experiments performed in sera are similar (Table 2, d ).
In a recent study, Biancotto et al. (20) have analyzed the role of anticoagulants (sodium heparin, acid citrate dextrose and EDTA) on the measurement of 72 analytes from 11 healthy donors. A total of 21 analytes overlapped with the 50 different cytokine/chemokine/ growth factors analyzed by Biancotto et al. (20) , while we have performed an additional two growth factors (PDGF-AABB and Flt-3 Ligand) in this studies. Our results are similar to the results of Biancotto et al. (20) for IL-8, IP-10, and PDGF-BB (more elevated in sera), and MCP-1 and IL-16 (more elevated in heparin). In contrast, VEGF showed significant differences between measurements in serum and all types of plasma, regardless of anticoagulant in the earlier study, we did not find it to be significantly different between the experimental conditions. In this study we have approximately 10 times larger sample size (107 vs. 11) and therefore a much better statistical power is expected.
In this study we have used Luminex multiplex beadbased technology, with the antibody kits purchased from Bio-Rad or Millipore (Materials and Methods). Earlier studies have compared the performance of multiplex microbead assays between various vendors and it was noted that for some analytes the consistency between the vendors is large (23, (38) (39) (40) . Though our conclusions are broadly applicable, specific care must be envisaged when other kits or vendors are used.
A limited number of studies have focused on the effect of anticoagulants used for sample collection in quantitative measurement of cytokine/chemokine levels in healthy subjects. In one of the earliest investigations on this issue, Thavasu et al. (10) suggested that the optimal conditions for blood collection for consistent immunoassay measurements of circulating recombinant cytokines are rapid processing at 4 C of EDTA anticoagulated blood. In a model of porcine blood cells, it was noted that heparin and EDTA differentially affected cytokine mRNA levels (41) . In FXa-activated human monocytes, Ben-Hadj-Khalifa et al. noted the anticoagulant effect on production of the anti-inflammatory cytokine IL-10 suggested cross-talk between inflammation and coagulation (42) . Preparation of serum includes removal of fibrinogen, platelets, and other circulating proteins from the plasma that could influence the presence or detection of an analyte on such a sample. Effects on coagulation and fibrinolysis appear to be mediated by different cytokines, IL-6 being most relevant for activation of coagulation and TNF playing a pivotal role in the induction of fibrinolytic responses. Also, during the coagulation cascade, cellular activation can release inflammatory mediators, that may affect cytokine levels. The reason for the differences in cytokine concentrations observed between the plasmas collected in different anticoagulants is not known. EDTA and citrate both sequester calcium to prevent coagulation, whereas heparin acts by binding to antithrombin. Cluster analysis (Fig. 4) supports the known facts that the mode of action of citrate and EDTA inhibit anticoagulation are more similarly than heparin or sera.
Cytokines, chemokines, and certain growth factors play an integral role in the regulation, coordination and persistence of the inflammatory process. Knowledge of the level of cytokine and chemokine concentrations in healthy subjects is necessary to determine if levels are aberrant in disease. Furthermore, the choice of cut-off level between "normal" and "elevated" or "decreased" needs to be carefully considered. The development of bead-based multiplex technology has made possible the simultaneous measurement of many molecules in very   FIG. 3 . Age dependent effects on the analytes in healthy subjects. Median dot plots of IL-1b (left panels), IL-7 (central panels), and TNF-a (right panels) grouped into age groups I (18-30 years, black circles), II (31-50 years, red squares), III (51-64 years, blue diamonds), and IV (65-85 years, green hexagons). The choice of anticoagulants (citrate, EDTA, or heparin) and serum is marked on the right. Symbols represent individual measurements in pg/ml and the horizontal bars are the respective median values of each group.
small amounts of sample. With the use of this technology, sample pooling can be avoided and individual information from each subject can be obtained. The utility of these measurements will depend on rigorous attention to detail in the collection and processing of samples in addition to assay precision. Our results emphasize the need to consider experimental design carefully when a study requires measurement of biomarkers in the peripheral blood. Cross comparison of levels or profiles of biomarker analytes performed in different anticoagulants or a combination of plasma and serum should be avoided. MMIA has the advantages in terms of efficiency of performance, precision and accuracy to measure multiple analytes, on par with ELISA. Though individual research groups might have a choice of anticoagulant, our group finds that EDTA provides consistent results across multitude of applications.
